Introducing APPC™ – Aromatic Porous Precipitated Complex
A purification platform designed for scalable biologics manufacturing.
Built to support existing and emerging antibody formats, simplify downstream processing, and reduce operational complexity in biologics manufacturing.
.png)
Need
IgG
IgA
IgM
Fc-Fusion
Proteins
The Future of Biologics Requires New Manufacturing
Infrastructure
Invested in global biologics manufacturing capacity
$200B+
As antibody therapeutics evolve beyond traditional IgG molecules, existing purification infrastructure is facing growing challenges in scalability, complexity, and compatibility with emerging antibody formats.
The next decade of biologics growth will be defined not just by the therapies we discover but by the infrastructure that enables them.
A Structural Shift in Downstream Purification Processing
APPC™ is designed to simplify purification workflows through a non-chromatographic capture architecture operating at neutral pH.
Broad Antibody
Compatibility
Designed for IgG, IgA, IgM, and acid-sensitive Fc-fusion proteins
APPC Advantages
Simplified
Processing
Ligand-free architecture designed to reduce downstream complexity
.png)
Scalable
Manufacturing
Designed without traditional chromatography columns and pressure limitations
Neutral pH Processing
Operates at neutral ~pH 7 to protect sensitive biologic molecules
Built to Address Key Bottlenecks
in Antibody Purification
APPC™ is designed to reduce capture processing time from hours to minutes, simplify purification workflows, and support improved downstream manufacturing economics as biologics production continues to scale.
.png)
.png)
.png)
.png)
Hours to Minutes
Lower production costs
Simplified Workflows
Built for
Growth
.png)
About Us
AromAb is a Netherlands-based biotech company entering its next stage of development, seeking strategic investment and industry partnerships to advance APPC™ toward pilot-scale validation and commercial readiness.
AromAb is a Netherlands-based biotech company entering its next stage of development, seeking strategic investment and industry partnerships to advance APPC™ toward pilot-scale validation and commercial readiness.
Tamir Levital
CEO & Co-Founder
Healthcare and medtech executive with extensive experience in company building, commercialization, and strategic growth.
.png)
Dr. Guy Patchornik
CSO & Co-Founder
Inventor of the APPC™ platform and Head of the Antibody Purification Laboratory at Ariel University.
Dr. Tamar Raz
Chair & Commercial Advisor
Commercialization and strategic partnerships executive supporting healthcare innovation.
Ronald Kompier
Scientific & Technical Advisor
Global vaccine development and biologics manufacturing expert.
Nadav Shichor, JD
Legal Advisor
Over 25 years of experience structuring and negotiating complex technology, collaboration, and intellectual property agreements.
Mar, 2026
Supports promising early-stage life sciences and biotechnology startups.
A important milestone in AromAb’s growth and entrepreneurial development journey.
Dec, 2025
The funding supports AromAb’s mission to advance APPC™ and drive innovation with positive societal impact.
News & Updates
Latest News
Follow AromAb's continued progress in biologics purification and manufacturing infrastructure
Jan, 2026
.png){kind=logo}
